Literature DB >> 8215632

Absence of antiphospholipid antibodies in Behçet's disease.

M Karmochkine, M C Boffa, B Wechsler, J C Piette, P Godeau.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8215632      PMCID： PMC1005127          DOI： 10.1136/ard.52.8.623-a

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  9 in total

1.  Absence of lupus anticoagulants in Behçet's disease.

Authors:  D Bang; H G Ji; Y S Choi; S Lee
Journal:  Yonsei Med J       Date:  1991-12       Impact factor: 2.759

Review 2.  Antiphospholipid antibodies.

Authors:  E N Harris
Journal:  Br J Haematol       Date:  1990-01       Impact factor: 6.998

3.  Anticardiolipin antibodies in Behçet's disease.

Authors:  R Bergman; M Lorber; M Lerner; R Brik; R Friedman-Birnbaum
Journal:  J Dermatol       Date:  1990-03       Impact factor: 4.005

4.  [Anticardiolipin antibodies in Behçet's disease].

Authors:  M Hamza; O Meyer
Journal:  Presse Med       Date:  1986 Jul 5-12       Impact factor: 1.228

5.  Anticardiolipin antibodies: occurrence in Behçet's syndrome.

Authors:  R G Hull; E N Harris; A E Gharavi; A Tincani; R A Asherson; G Valesini; A M Denman; G Froude; G R Hughes
Journal:  Ann Rheum Dis       Date:  1984-10       Impact factor: 19.103

6.  Negative anticardiolipin antibodies and vascular complications in Behçet's syndrome.

Authors:  J Efthimiou; E N Harris; G R Hughes
Journal:  Ann Rheum Dis       Date:  1985-10       Impact factor: 19.103

7.  Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus.

Authors:  E N Harris; A E Gharavi; M L Boey; B M Patel; C G Mackworth-Young; S Loizou; G R Hughes
Journal:  Lancet       Date:  1983-11-26       Impact factor: 79.321

8.  Anticardiolipin antibodies in Behçet's syndrome: a predictor of a more severe disease.

Authors:  R M Pereira; C R Gonçalves; C Bueno; E de S Meirelles; W Cossermelli; R M de Oliveira
Journal:  Clin Rheumatol       Date:  1989-06       Impact factor: 2.980

9.  Antiphosphatidylethanolamine antibody as the sole antiphospholipid antibody in systemic lupus erythematosus with thrombosis.

Authors:  M Karmochkine; P Cacoub; J C Piette; P Godeau; M C Boffa
Journal:  Clin Exp Rheumatol       Date:  1992 Nov-Dec       Impact factor: 4.473
  9 in total
  1 in total

Review 1.  Anticardiolipin (aCL) antibodies in a patient with Behçet's syndrome with vena cava inferior thrombosis.

Authors:  D G Ebo; P G Bracke; L S De Clerck; L M Francx; W J Stevens
Journal:  Clin Rheumatol       Date:  1997-01       Impact factor: 2.980
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.